StockData
Guardian Pharmacy Services, Inc. logo

Guardian Pharmacy Services, Inc. (GRDN) stock

GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30160% above fair value
$50.33+0.90 (+1.82%)

Close on Nov 17, 2026Market cap $3.19BP/E –Yield –

Guardian Pharmacy Services operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Guardian Pharmacy Services's operating income for the twelve months ending Jun 30, 2026 was $85.44M. For fiscal 2025 it was $72.70M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$72.70M–
FY2024Dec 31, 2024-$62.92M-253.7%
FY2023Dec 31, 2023$40.95M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$20.64M+64.1%
Q1 FY2026Mar 31, 2026$17.68M+35.9%
Q4 FY2025Dec 31, 2025$30.76M+83.6%
Q3 FY2025Sep 30, 2025$16.35M–
Q2 FY2025Jun 30, 2025$12.58M-26.0%
Q1 FY2025Mar 31, 2025$13.01M+63.9%
Q4 FY2024Dec 31, 2024$16.76M+7.9%
Q3 FY2024Sep 30, 2024-$104.61M–
Q2 FY2024Jun 30, 2024$17.01M–
Q1 FY2024Mar 31, 2024$7.93M–
Q4 FY2023Dec 31, 2023$15.52M–
Q3 FY2023Sep 30, 2023-$6.33M–

More Guardian Pharmacy Services figures

See a number that looks wrong?